Immuneering Corp. Class AIMRX

13F holders, Q1 2025 (March 31)
35holders −7
5new positions
12sold out
1famous investor
$1.52avg. 13F price*

At the end of Q1 2025, 35 institutions reported holding Immuneering Corp. Class A (IMRX) in their 13F filings, down 7 from Q4 2024. 5 opened new positions and 12 sold out. The largest holders were Vanguard Group Inc. ($1.6M), Marshall Wace, LLP ($1.2M) and T. Rowe Price Associates Inc. ($1.0M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).

Company
Immuneering Corp. Class A
CUSIP
45254E107
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 51Q1 2024Q2 2024: 59Q2 2024Q3 2024: 38Q3 2024Q4 2024: 42Q4 2024Q1 2025: 35Q1 2025Q2 2025: 39Q2 2025Q3 2025: 68Q3 2025Q4 2025: 85Q4 2025Q1 2026: 95Q1 2026Q2 2026: 111Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions5$66K
Exits12$898K

All 13F filers, Q4 2024 → Q1 2025: 916,571 shares bought and 720,438 shares sold, net +196,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 35 holders

Vanguard Group Inc. 0.00% No change 1,056,922 $1.6M
Marshall Wace, LLP 0.00% Add +3669.9% 807,969 $1.2M
T. Rowe Price Associates Inc. 0.00% Reduce -14.1% 659,009 $1.0M
Morgan Stanley 0.00% Add +2.9% 467,226 $710K
BlackRock, Inc. 0.00% Reduce -0.7% 316,530 $481K
Southport Management, L.L.C. 1.61% Add +13.9% 245,000 $372K
Geode Capital Management, LLC 0.00% Add +8.4% 225,817 $343K
HighTower Advisors, LLC 0.00% Add +17.7% 83,960 $128K
Manufacturers Life Insurance Company, The 0.00% Add +0.0% 82,667 $126K
State Street Corp. 0.00% No change 78,535 $119K
TD Asset Management Inc 0.00% Reduce -52.9% 71,066 $108K
Bridgeway Capital Management, LLC 0.00% Add +17.7% 60,449 $92K
Tidemark, LLC 0.02% No change 44,400 $67K
Northern Trust Corp. 0.00% No change 39,729 $60K
Two Sigma Investments, LP 0.00% Reduce -29.3% 35,757 $54K
First Manhattan Co. Llc. 0.00% No change 32,325 $49K
Bank of America Corp. 0.00% Reduce -7.1% 28,854 $44K
UBS Group AG 0.00% Reduce -45.6% 28,551 $43K
Millennium Management 0.00% Reduce -77.6% 23,065 $35K
Jane Street Group, LLC 0.00% New 20,869 $32K
PNC Financial Services Group, Inc. 0.00% No change 20,000 $30K
Dimensional Fund Advisors LP 0.00% No change 13,366 $20K
Charles Schwab Investment Management Inc. 0.00% New 12,000 $18K
Engineers Gate Manager LP 0.00% New 10,607 $16K
Barclays PLC 0.00% No change 9,924 $15K
CIBC Private Wealth Group LLC 0.00% No change 10,000 $13K
Tower Research Capital LLC (TRC) 0.00% Add +163.7% 6,328 $10K
Federated Hermes, Inc. 0.00% Add +3.0% 3,954 $6K
JPMorgan Chase & Co. 0.00% No change 1,974 $3K
Citigroup Inc. 0.00% Reduce -65.3% 796 $1K
EverSource Wealth Advisors, LLC 0.00% No change 345 $524
BNP Paribas Financial Markets 0.00% Reduce -17.8% 287 $436
US Bancorp \de 0.00% New 228 $347
SBI Securities Co., Ltd. 0.00% No change 74 $112
Royal Bank of Canada 0.00% New 1 $0

"% of holder's portfolio" is IMRX's weight in each manager's 13F, not the share of Immuneering Corp. Class A the manager owns.